Inventiva S.A. Share Price & Technical Analysis
IVA · $5.10 (-0.78%)
Healthcare / Biotechnology
$5.10
-0.78%
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients…
Price chart
Seasonality
May has 2 positive and 2 negative years (last 5 years shown)
0% return in May, 20% avg return in past 3 year May month.
22% return in 2026, 30% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 32% | 8% | -11% | -7% | 0% | – | – | – | – | – | – | – | 22% |
| 25 | 9% | 33% | -9% | 23% | -11% | -3% | 6% | 94% | 5% | -27% | -2% | 9% | 128% |
| 24 | -16% | -5% | 0% | -22% | 19% | -17% | -26% | 0% | -17% | 42% | 0% | -22% | -64% |
| 23 | 29% | -18% | -31% | -23% | 50% | 3% | 3% | -10% | 11% | -10% | 14% | 7% | 25% |
| 22 | -12% | 7% | -11% | -15% | -5% | -37% | -16% | -6% | -11% | 21% | -9% | 7% | -86% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.19B
P/E ratio
—
52W high
$7.98
52W low
$2.85
Volume
10,452
Beta
0.88
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Inventiva S.A. share price today?
- Inventiva S.A. (IVA) last traded around $5.10 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does IVA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for IVA. Download the app for real-time alerts.
- How can I analyze Inventiva S.A. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.